SCHEMBL28972762

SCHEMBL28972762

CC(C)(C)OC(=O)N1CCN(c2ncc(C(F)(F)F)cc2[N+](=O)[O-])C(CCO)C1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.43
NR1H3 Q13133 1/20 0.43
GPR119 Q8TDV5 9/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
MET P08581 2/20 0.38
CXCR3 P49682 1/20 0.38
PRKCQ Q04759 1/20 0.37
ENPP2 Q13822 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29274299 0.93 NR1H2 (0.44) NR1H2NR1H3GPR119MEN1KMT2A
SCHEMBL29274214 0.93 NR1H2 (0.44) NR1H2NR1H3GPR119MEN1KMT2A
SCHEMBL29274284 0.88 NR1H2 (0.42) NR1H2NR1H3GPR119MEN1KMT2A
SCHEMBL31381998 0.87 CXCR3 (0.43) GPR119MEN1KMT2ACXCR3CYP1A2
SCHEMBL31382096 0.87 CXCR3 (0.43) GPR119MEN1KMT2ACXCR3CYP1A2
SCHEMBL29088950 0.87 MEN1 (0.44) NR1H2NR1H3GPR119MEN1KMT2A
SCHEMBL26914941 0.86 NR1H2 (0.46) NR1H2NR1H3GPR119MEN1KMT2A
SCHEMBL29088853 0.86 NR1H2 (0.46) NR1H2NR1H3GPR119MEN1KMT2A
SCHEMBL26914913 0.86 NR1H2 (0.46) NR1H2NR1H3GPR119MEN1KMT2A
SCHEMBL29274217 0.85 GPR119 (0.47) GPR119METPRKCQ

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117083274-A Fused ring heterocyclic derivative and application thereof in medicine 四川海思科制药有限公司 2023-11-17 CN disclosed
CN-115677664-A Pyridazinones as PARP7 inhibitors 武汉人福创新药物研发中心有限公司 2023-02-03 CN disclosed